Pay in 4 interest-free payments of $50.00 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
producing high-avidity binding that substantially exceeds the affinity of monovalent GalNAc ligands and closely mimics the geometry of clinically validated Tri-GalNAc targeting moieties used in approved GalNAc-siRNA therapeutics
C8H16O5S / 224
the sialylation of therapeutic proteins can affect their serum half-life
C29H44D6O2 / 436
(+)-Vitamin D2-d3
AG423000: β-D-Gal-Ethyl-Amine Pack Size:100 mg producing high-avidity binding that substantiallyC8H17NO6 223. 22 A D galactose ligand equipped with an amine functionalized linker through a short ethyl spacer. The primary amine can be covalently coupled with N hydroxysuccinimide (NHS) activated esters to form stable amide bonds, providing a straightforward route to conjugate the ligand onto NHS activated molecules and surfaces. This compound provides a anomeric galactose building block for glycoconjugate synthesis, glycomimetic research, and the
US$ 27.60
US$ 52.80
US$ 12.90
US$ 31.70
